FOXM1 and neoplasm: Recently, Bu et al. (2024) found a novel peptide derived from the C-terminus of forkhead box M1 (FOXM1), named M1-20, that enhances the ubiquitination and degradation of CDK1 through proteasome pathway, with potential inhibitory effects for tumor cells [74].